AMICUS: An Epidemic of Goodwill

URGENT APPEAL

THE BIG PICTURE

THE THEORY

THE PATH

THE CHALLENGE

AND YOU

EUROPE TO AFRICA

Sports AIDS Life

DONATE

AMICUS 100

CONTACT

Dr. Jonas Salk, the pioneering immunologist who developed the first polio vaccine, called HIV/AIDS the metaphoric disease of our time.

There are 8,000 new HIV infections daily worldwide and no preventative vaccine is in sight.  

For every 2 HIV-infected individuals placed on anti-retroviral therapy (ARV), another 5 are diagnosed. 

T-cell vaccination, as the HIV-immunotherapy is called, focuses on re-establishing immunological memory within the immune system of the HIV-infected individual.  

While remaining HIV positive for life, this "post-infection vaccine effect" intends to delay, perhaps indefinitely in some, progression towards AIDS.  also important, no toxicity has been observed in our studies to date.
  
To Dr. Salk, T-cell vaccination immunotherapy would effect a "live and let live" solution in HIV-infection.


AMICUS For AIDS is the public outreach campaign of the Global Consortium for Immunotherapy, a collaborative program between Hadassah University Hospital and the Human Futures Foundation, a US registered 501(c)(3) charity (EIN:22-3360768), also registered in Switzerland (No. Fed. CH-660-1653009-0), France (W751200152)  and the United Kingdom (UK charity no. 112558).  
Learn more at www.humanfutures.org